Adare Pharmaceutical Technologies (PT) is the specialty CDMO business unit of Adare, a global specialty pharmaceutical company. A science-driven provider of dosage form solutions for the healthcare industry – with expertise in taste masking and customized drug release – Adare PT is a leading partner to pharmaceutical companies across branded, specialty, 505b2, generic and OTC segments. With over 30 years of proven legacy, Adare PT focuses on oral dosage forms for small molecules across all therapeutic areas. To learn more, email us at BusDev@adarepharma.com.
Albumedix is a science-driven, biotechnology company focused on enabling the creation of superior biopharmaceuticals utilizing our albumin-based drug enhancing technologies. We partner with excellence to improve therapies for people with serious diseases. We are proud to be recognized as the world leader in recombinant human albumin with products and technologies used in clinical and marketed drugs by pharmaceutical companies worldwide. Headquartered in Nottingham, England with more than 80 people all committed to improving patient quality of life. We are just as passionate about albumin and albumin-enabled therapies today as we were when we started 30 years ago.
Asahi Kasei is a highly diversified Japanese supplier of high-performance materials for various industries, including automotive, energy, electronics, housing and health care. In the fields of pharma- and nutraceuticals, we offer functional excipients. For many decades Asahi Kasei stands for quality, reliability and performance and is dedicated to “Creating for Tomorrow”.
Our key product is Ceolus, functional grades of microcrystalline cellulose (MCC) with outstanding compactability and flowability due to a special particle structure. This allows for avoiding typical formulation challenges like tablet mass segregation, capping, slow/fast disintegration, low tablet hardness or the changing of the API structure. Celphere, Asahi Kasei’s MCC spherical cores allow the combination of incompatible APIs in one tablet, achieve different release profiles and improve the acceptability of products. Special grades of our pregelatinized starch PC-10 can be applied for the protection of moisture sensitive APIs in the formulation.
Our functional excipients prove to be solutions to our customer’s daily challenges
Focusing On Your Formulation Needs
BASF produces excipients and active ingredients of outstanding quality and performance. With our unique expertise in polymer chemistry, our research & development capabilities and our clear commitment to developing excipients, BASF has continuously created solutions that contribute to your success and to more efficient pharmaceuticals. We deliver value added functional solutions to your formulation challenges by leveraging our expertise in delivery systems and related technologies. Our team of experienced industry specialists support you in developing effective, reliable formulations – giving you a vital advantage in a highly competitive market.
Our Platforms – Your Access To BASFs Solution Offer
BASF has been committed to the pharmaceutical industry since we introduced our original Kollidon® in the early 20th century. Since then we have continuously expanded our solution offer. Today we solve unmet formulation needs and offer intelligent solutions for today and tomorrow's challenges in drug formulation. Our four dedicated solution platforms based on current pharmaceutical market needs help you to find what you are looking for – faster than ever before. We can help with formulation challenges related to Instant and Modified Release, Solubilization, Skin Delivery, Softgels and Biologic Solutions
BDD is a specialist pharmaceutical development company providing expertise across all areas of drug delivery. Our service, customised to our clients individual needs, is inclusive of project design, optimal formulation development and lean clinical evaluation.
Our patented, time release technology - OralogiK™ provides unrivalled control of drug release in vivo – delivery at the right place, at the right time.
OralogiK™ enables the delivery of single, multi-dose or drug combinations at pre-determined times post dose. Benefits include:
galenIQ™ - The filler-binder excipient that makes medicine taste better
BENEO, a division of the Südzucker Group, offers galenIQTM (Isomalt Ph.Eur., BP, USP-NF, JP), which is a water-soluble pharmaceutical excipient filler-binder.
galenIQ™ combines a multitude of outstanding characteristics, suitable for a wide range of pharmaceutical applications. In fact, it also has a sweetness and taste profile that is very similar to sucrose and therefore it is frequently used to improve the palatability of bitter-tasting active pharmaceutical ingredients (APIs), plant extracts and probiotics. galenIQ™ is non-cariogenic and shows a low glycaemic index which makes it the optimal choice for the formulation of a broad variety of dosage forms, such as chewable tablets, compressed lozenges, oro-dispersible mini-tablets, effervescents, sachets, and cough syrups.
BENEO is a member of the International Pharmaceutical Excipients Council (IPEC) and produces galenIQ™ under GMP conditions for pharmaceutical products.
Cambridge Design Partnership is a leading product and technology innovation partner with offices in Cambridge, UK and Palo Alto, USA. We are experienced in drug delivery device design, development, prototype and short-run manufacturing for some of the world’s largest companies. Our experts in engineering, human factors and industrial design are able to take combination products through a full design cycle and submission, to enable you to launch a product that is customer focused and commercially effective. Certified to ISO 13485/9001.
Captisol is a patent-protected, chemically modified cyclodextrin with a structure designed to optimize the solubility and stability of drugs. Captisol was invented and initially developed by scientists in the laboratories of Dr. Valentino Stella, University Distinguished Professor at the University of Kansas’ Higuchi Biosciences Center for specific use in drug development and formulation. This unique technology has enabled several FDA-approved products, including Amgen’s Kyprolis®, Baxter International’s Nexterone®, Spectrum’s EVOMELA® and Melinta Therapeutics’ Baxdela™. There are many Captisol-enabled products currently in various stages of development.
We create, make and sell speciality chemicals that deliver real benefits to a range of diverse products including health and beauty, engine lubricants, plastics and many more.
Our business is split into three core market sectors: Personal Care; Life Sciences made up of Crop Care and Health Care and Performance Technologies made up of Coatings and Polymers; Geo Technologies; Home Care; Lubricants and Polymer Additives. We also have an Industrial Chemicals business area. In all areas of our business our focus is on developing and delivering innovative ingredients sustainably.
Crux is a product development consultancy serving the pharmaceutical industry with a fully integrated service wrapped around solid technical knowledge. Our highly experienced technical team consists of designers, engineers, human-factors experts, electronics and software specialists who champion evidence-based problem-solving. We couple this scientific approach with world-class facilities & equipment to develop device solutions that perform in the real world.
Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global health care world. Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our health care offering and its three pillars Bio Care, Pharma Care and Med Care, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. Partnering up with the world’s top pharmaceutical and medical companies, we are a vital link and stand by our mission to ensure all patient’s safety and improve patients’ lives.
DFE Pharma is the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder formulations with a heritage in lactose, starch and superdisintegrants. With the addition of MCC to our portfolio DFE Pharma uniquely offers world's main excipient categories, unlocking potential synergies for you to increase your efficiency. Contact us on www.dfepharma.com
Foster Delivery Science focuses solely on Hot Melt Extrusion and extrusion processes to blend client API’s with polymers for several possible purposes: Solubility and bioavailability enhancement; create local delivery solutions such as drug loaded films, implants and fibers; create delivery or release profiles; and capture the powerful mixing capabilities of twin screw extruders. Operating from our new GMP facility 75 minutes from Boston in CT, we provide formulation development services, scale up, clinical trial material and ready for GMP manufacturing.
As a global materials science company, Gore collaborates with pharmaceutical companies to design materials-based solutions that fit their requirements for product purity, process effectiveness and device performance. Our newest innovation, the GORE ImproJect Plunger for pre-filled syringes protects sensitive biologics from silicone-induced particle formation and protein aggregation since Gore has eliminated the need for silicone in both the plunger and barrel.
Halo Labs is all about particle analysis. We live to find particles, analyze them, count them, and help our customers characterize them to better their biopharmaceutical products. Using the latest optics and innovative algorithms, Horizon, our flagship product, can analyze sub visible and visible particles, including protein aggregates. It utilizes a plate-based approach that enables high-throughput (up to 96 samples/run), low-volume (as little as 30 µL) particle analysis in a wide-range of samples from pre-formulation through quality control. Come by our booth to learn more or visit us anytime at halolabs.com.
LEUKOCARE is a privately owned, product-focused, clinical-stage biotechnology company founded in 2003 and headquartered in Martinsried/Munich, Germany.
LTS is the global leader in the development and manufacture of transdermal systems and oral thin films with additional innovative technologies in development. The products developed by LTS comprise a multitude of innovations, such as first and only patch for treatment of Alzheimer and the only patch against Parkinson’s and Restless-Legs-Syndrome, which is the first medication in the world available only as a patch. The innovation capability of LTS led the way for oral thin film products on the market with the introduction of Listerine® Pocketpaks®, which dominate the North American market. LTS supports its cooperation partners from product inception through commercialization in our FDA approved facilities in Germany and USA. More than 3,000 patents reinforce the top position of LTS group in development of its technologies. LTS Lohmann services include: Feasibility studies Full product development Clinical studies phase I-IV Scale-up and process development Commercial manufacturing For transdermal therapeutic systems, topical patches and oral thin films (OTF)
Lubrizol Life Science is your trusted development partner, specializing in helping customers from idea to execution by designing and producing effective drug delivery products. We are your preferred Contract Development and Manufacturing Organization (CDMO) for complex pharmaceuticals, providing differentiated polymers and excipients, state-of-the-art design, development and manufacturing services. Staffed by industry experts, Lubrizol Life Science offers drug product formulation and a comprehensive suite of supporting services. Lubrizol Life Science: Driven by innovation, powered by partnership.
MedPharm is the world’s leading contract provider of topical and transdermal product design and formulation development services. MedPharm are experts at reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through their unique, cost-effective and industry-leading performance testing models. Well established as the global leaders in dermatology, nail, mucosal membrane and transdermal product development, MedPharm can also offer innovative solutions for ophthalmic and airway preparations recognised for their scientific rigour by regulators and investors. MedPharm has fully established R&D centres in the USA and UK and has its global HQ in Guildford, UK.
Merck KGaA, Darmstadt, Germany is a leading science and technology company in healthcare, life science and performance materials. We offer more than 400 pharmaceutical formulation raw materials for solid, liquid and semi-solid dosage forms, a wide range of active pharmaceutical ingredients and drug delivery compounds which include activated PEGs, lipids, PEG lipids for bioavailability enhancement. In addition, our Emprove® Program provides extensive regulatory documentation to facilitate risk assessment and qualification processes. Through dedicated collaboration on new scientific and engineering insights, we serve as a strategic partner to help advance the promise of life saving therapies. For more information on the company's portfolio, please click here.
MUNIT is a consultancy company, operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics.
In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy) making the best out of 40 years of leadership in the micronization sector.
MUNIT is your access point to JETPHARMAs and MICROCHEMs services:
Pfanstiehl Inc. is a cGMP Manufacturer of High Purity Low Endotoxin components such as Trehalose, Sucrose, Mannitol, Maltose, Galactose (non-animal), Mannose and Ribose for Biologics, Biosimilars, Vaccines, Cell Culture Media and Injectables (liquid & lyo) located in Waukegan Illinois USA. Pfanstiehl has been in operation since 1919, focusing on both Biopharmaceutical excipients / critical components & Pharmaceutical HPAPIs / APIs (generic and on contract manufacturing base). Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, in gram to multi-ton commercial quantities.
PMC Isochem offers contract research, custom manufacturing, catalogue products and innovative solutions for Pharmaceutical companies worldwide. Our offer addresses three major areas:
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
Roquette is a global leader in plant-based ingredients and a pioneer of new vegetal proteins.
Making life better!
The safety of your patients is your first objective. That's why the quality and stability of your formulations are your ultimate challenge, and ours too.
As a long-established global provider of plant-based excipients and life-saving active ingredients for the pharmaceutical and biopharmaceutical industries, Roquette offers a competitive broad-range of customer-focused solutions.
Roquette currently operates in over 100 countries, has a turnover of around 3.3 billion euros and employs 8,400 people worldwide.
Shin-Etsu PFMD is the distribution organization of Shin-Etsu Chemical Co., Ltd. Japan and SE Tylose, Wiesbaden Germany and is registered in Wiesbaden. It is located at the Industrial Park Kalle-Albert in Wiesbaden. Together with our distributors, we are the exclusive business partners for our customers and multi national key accounts in the pharmaceutical- and the food industry. SE PFMD manages a regional, centralized warehouse for all products to be able to supply the customers in Europe on short-term base whenever necessary. SE PFMD will manage logistic for customers in other regions independent from Shin-Etsu´s production sites. For our pharma customers we offer with our technical application lab the possibility to optimize their processes if required. Our products are covering a very wide range of applications and they fully comply with FDA, USP/NF, JP and EP requirements. Pharmaceutical Excipients: Cellulose ether excipient is a pharmacologically inactive substance used as a carrier for the active ingredients in medication. PHARMACOAT® – Water-Soluble Film Coating Agent METOLOSE® – Binder and Thickening Agent METOLOSE® SR – Sustained release agent for hydrophilic matrix system L-HPC – Disintegrant with Binding Properties, Multifunctional Excipient HPMCP – Enteric Coating Agent Shin-Etsu AQOAT® – Enteric Coating Agent, Solid Dispersion Polymer Tylopur® – Low- and high viscosity Hypromellose
Our core competencies consist of design, development and production of mechatronic drive systems. Since 1936, our focus has been on innovation, best in class quality and service which is our key to success for worldwide OEM customers. Sonceboz is ISO 13485 certified and active in wearable drug delivery, medical devices and laboratory industry. Pharma companies looking for Large Volume Injectors for high viscosity drugs, Dual Cartridge or Auto-reconstitution Injectors will find interesting solutions in Sonceboz's new drug Delivery Device Platform. Customized technology modules like motor-drives, electronics, pumps and needle insertion systems are available for Medical device manufacturers. Address: Rue Rosselet Challandes - 5 2605 Sonceboz Switzerland
Stéarinerie Dubois is a French family-owned company established in 1820 and specializing in the production of GMP excipients for pharmaceutical, veterinary and life sciences markets.
Our lipid-based GMP excipients are used for oral, topical, rectal, vaginal and parenteral administration routes.
They are well known for their quality and their functionality: lubricants, taste-masking agents, bioavailability enhancers, sustained release vehicles, emulsifiers, solubilizers, thickeners and spreading agents.
Quality standards: IPEC-GMP, ISO 9001, ISO 14001, FSSC 22000, RSPO, GMP, Kosher.
Surface Measurement Systems develop and engineer gravimetric sorption analyzers and inverse gas chromatography instruments for physico-chemical characterization of solid state materials. Our instruments can be used for studying sorption and desorption isotherms, vapor and gas diffusion kinetics, hysteresis effects, stability studies, water activity, phase transformations, amorphous content, permeability, surface energy heterogeneity, dispersive and acid-base surface energy, solubility parameters, heats of adsorption and works of adhesion and cohesion.
Upperton Pharma Solutions is an independent CDMO providing specialist Spray Drying and formulation services to the Pharmaceutical and Biotechnology industries. The company is a world-leader in Spray Drying technology, and offers a complete development package, from early stage feasibility studies and formulation development, to process optimisation, scale up and clinical trial (IMP) manufacturing, supporting a range of dosage forms. Comprehensive product testing and ICH stability studies are available through an extensive range of analytical capabilities.
Based in Nottingham, UK, and founded in 1999, our primary focus has always been on the versatile technology of Spray Drying and we have built up the expertise to support even the most challenging of molecules. The company has an extensive, multinational client-base, ranging from small start-ups to top pharma companies and we pride ourselves on our client-focused, flexible approach and scientific excellence.
ZERION has pioneered the patented Dispersome® technology that greatly enhances the solubility of poorly soluble drugs and improves bioavailability and therapeutic outcomes for the patients. The Dispersome® technology is based on preparing stable amorphous formulations by mixing high loads (more than 50% w/w) of the drug compound with whey protein, a by-product from cheese production. The Dispersome® technology has already proven its value in enabling the development of novel drug candidates. ZERION develops its own proprietary drug formulations and offers the Dispersome® technology to established pharma companies as a means to solve their most challenging drug solubility problems. ZERION was established in 2019 as a spinout from the University of Copenhagen based on almost a decade of research